Raymond James Financial Inc. Invests $2.33 Million in Azenta, Inc. (NASDAQ:AZTA)

Raymond James Financial Inc. purchased a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 46,612 shares of the company's stock, valued at approximately $2,331,000. Raymond James Financial Inc. owned about 0.10% of Azenta at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the company. Picton Mahoney Asset Management increased its stake in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the last quarter. Headlands Technologies LLC acquired a new position in Azenta during the fourth quarter worth $40,000. KBC Group NV boosted its position in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the last quarter. Assenagon Asset Management S.A. bought a new position in shares of Azenta during the 4th quarter worth approximately $200,000. Finally, Landscape Capital Management L.L.C. purchased a new position in shares of Azenta in the 4th quarter worth about $217,000. Institutional investors own 99.08% of the company's stock.

Azenta Stock Performance

Shares of AZTA traded up $0.73 during mid-day trading on Friday, reaching $26.96. The stock had a trading volume of 774,940 shares, compared to its average volume of 653,538. Azenta, Inc. has a 12 month low of $24.06 and a 12 month high of $63.58. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -9.05 and a beta of 1.66. The business has a fifty day moving average of $33.14 and a 200 day moving average of $42.63.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AZTA. Evercore ISI increased their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC increased their price objective on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a "hold" rating in a research note on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.